Inflammation, Microbiome and Immunosurveillance France

Research

Date range: 1 August 2022 - 31 July 2023

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Inflammation, Microbiome and Immunosurveillance published between 1 August 2022 - 31 July 2023 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Inflammation, Microbiome and Immunosurveillance
Count Share
3 0.39

Outputs by subject (Share)

Outputs by subject
Subject Count Share
3 0.39
2 0.35

Share output for the past 5 years

Share per year
2018 2019 2020 2021 2022*
0.18 0.35 0.20 0.04 0.16

Compare Inflammation, Microbiome and Immunosurveillance with other institutions

*Note: 2022 data contains Share for article affiliations from newly added health-science journals.

Nature Strategy Reports

Nature Strategy Reports gives you simple insights to support decisions that impact your organisation

The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.

Get started

Collaboration

Date range: 1 August 2022 - 31 July 2023

International vs. domestic collaboration by Share

  • 83.74% Domestic (64 institutions)
  • 16.26% International (21 institutions)

Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators with Inflammation, Microbiome and Immunosurveillance by Share*

  1. Inflammation, Microbiome and Immunosurveillance and National Institute for Health and Medical Research (INSERM) (0.91)
    Inflammation, Microbiome and Immunosurveillance0.39
    National Institute for Health and Medical Research (INSERM)0.52
  2. Inflammation, Microbiome and Immunosurveillance and Assistance Publique-Hôpitaux de Paris (AP-HP) (0.78)
    Inflammation, Microbiome and Immunosurveillance0.39
    Assistance Publique-Hôpitaux de Paris (AP-HP)0.39
  3. Inflammation, Microbiome and Immunosurveillance and University of Paris-Saclay (0.72)
    Inflammation, Microbiome and Immunosurveillance0.39
    University of Paris-Saclay0.33
  4. Inflammation, Microbiome and Immunosurveillance and French National Centre for Scientific Research (CNRS) (0.57)
    Inflammation, Microbiome and Immunosurveillance0.39
    French National Centre for Scientific Research (CNRS)0.18
  5. Inflammation, Microbiome and Immunosurveillance and Diseases and Hormones of the Nervous System (DHNS) (0.54)
    Inflammation, Microbiome and Immunosurveillance0.23
    Diseases and Hormones of the Nervous System (DHNS)0.31
  6. Inflammation, Microbiome and Immunosurveillance and The French Alternative Energies and Atomic Energy Commission (CEA) (0.45)
    Inflammation, Microbiome and Immunosurveillance0.39
    The French Alternative Energies and Atomic Energy Commission (CEA)
  7. Inflammation, Microbiome and Immunosurveillance and National Research Institute for Agriculture, Food and Environment (INRAE) (0.45)
    Inflammation, Microbiome and Immunosurveillance0.39
    National Research Institute for Agriculture, Food and Environment (INRAE)
  8. Inflammation, Microbiome and Immunosurveillance and Sorbonne University (0.44)
    Inflammation, Microbiome and Immunosurveillance0.39
    Sorbonne University
  9. Inflammation, Microbiome and Immunosurveillance and National Institute for Research in Computer Science and Control (INRIA) (0.42)
    Inflammation, Microbiome and Immunosurveillance0.39
    National Institute for Research in Computer Science and Control (INRIA)
  10. Inflammation, Microbiome and Immunosurveillance and CentraleSupélec (0.41)
    Inflammation, Microbiome and Immunosurveillance0.39
    CentraleSupélec

Top 10 international collaborators with Inflammation, Microbiome and Immunosurveillance by Share*

  1. Inflammation, Microbiome and Immunosurveillance and The University of Edinburgh (0.46)
    Inflammation, Microbiome and Immunosurveillance0.23
    The University of Edinburgh0.23
  2. Inflammation, Microbiome and Immunosurveillance and MetP Pharma AG (0.31)
    Inflammation, Microbiome and Immunosurveillance0.23
    MetP Pharma AG
  3. Inflammation, Microbiome and Immunosurveillance and The University of Sheffield (0.24)
    Inflammation, Microbiome and Immunosurveillance0.12
    The University of Sheffield0.12
  4. Inflammation, Microbiome and Immunosurveillance and Technical University of Munich (TUM) (0.19)
    Inflammation, Microbiome and Immunosurveillance0.12
    Technical University of Munich (TUM)
  5. Inflammation, Microbiome and Immunosurveillance and Babraham Institute (0.18)
    Inflammation, Microbiome and Immunosurveillance0.12
    Babraham Institute
  6. Inflammation, Microbiome and Immunosurveillance and University of Cambridge (0.18)
    Inflammation, Microbiome and Immunosurveillance0.12
    University of Cambridge
  7. Inflammation, Microbiome and Immunosurveillance and UK DRI at Cardiff (UK DRI Cardiff) (0.16)
    Inflammation, Microbiome and Immunosurveillance0.12
    UK DRI at Cardiff (UK DRI Cardiff)
  8. Inflammation, Microbiome and Immunosurveillance and Addenbrooke's Hospital (0.15)
    Inflammation, Microbiome and Immunosurveillance0.12
    Addenbrooke's Hospital
  9. Inflammation, Microbiome and Immunosurveillance and Instituto de Inmunología Clínica y Experimental de Rosario (IDICER) (0.14)
    Inflammation, Microbiome and Immunosurveillance0.12
    Instituto de Inmunología Clínica y Experimental de Rosario (IDICER)
  10. Inflammation, Microbiome and Immunosurveillance and UK Dementia Research Institute (UK DRI) (0.14)
    Inflammation, Microbiome and Immunosurveillance0.12
    UK Dementia Research Institute (UK DRI)

*Share is the fractional count allocated to an institution for an article that takes into account the percentage of authors from that institution and the number of affiliated institutions that contributed to the article. The horizontal stacked bar charts above indicate the Share contributed by each institution in the bilateral collaboration. If the Share is not shown, hover over the bar to display it.

Nature Careers

Need to hire scientific researchers?

Nature Careers is visited by over 180,000 active jobseekers per month that you can target directly with your role. Application response rates have increased by 28% on average over 2022 averages.

Relationships

Partner Institutions

Inflammation, Microbiome and Immunosurveillance is a research collaboration whose article contributions are accrued to its participating partner institutions below.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.